REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5 | -100.0% | 41,637 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | -44.4% | 41,637 | 0.0% | 0.00% | – |
| Q2 2022 | $36,000 | -65.4% | 41,637 | 0.0% | 0.00% | – |
| Q1 2022 | $104,000 | +52.9% | 41,637 | +57.6% | 0.00% | – |
| Q4 2021 | $68,000 | -45.2% | 26,419 | -2.5% | 0.00% | – |
| Q3 2021 | $124,000 | -33.7% | 27,091 | -0.5% | 0.00% | – |
| Q2 2021 | $187,000 | +3.9% | 27,229 | +10.3% | 0.00% | – |
| Q1 2021 | $180,000 | +7.1% | 24,689 | +18.3% | 0.00% | – |
| Q4 2020 | $168,000 | -21.1% | 20,875 | 0.0% | 0.00% | – |
| Q3 2020 | $213,000 | +59.0% | 20,875 | +4.0% | 0.00% | – |
| Q2 2020 | $134,000 | +76.3% | 20,065 | +19.0% | 0.00% | – |
| Q1 2020 | $76,000 | -62.7% | 16,864 | -50.0% | 0.00% | – |
| Q4 2019 | $204,000 | +72.9% | 33,728 | +100.0% | 0.00% | – |
| Q3 2019 | $118,000 | +8.3% | 16,864 | 0.0% | 0.00% | – |
| Q2 2019 | $109,000 | -0.9% | 16,864 | +27.3% | 0.00% | – |
| Q1 2019 | $110,000 | -24.7% | 13,251 | -50.0% | 0.00% | – |
| Q4 2018 | $146,000 | – | 26,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 367,346 | $926,000 | 0.15% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,950,002 | $4,914,000 | 0.11% |
| Claret Asset Management Corp | 95,430 | $240,000 | 0.05% |
| Annandale Capital, LLC | 43,532 | $110,000 | 0.04% |
| ARK Investment Management | 861,798 | $2,172,000 | 0.01% |
| Virtu Financial LLC | 26,864 | $68,000 | 0.01% |
| Ancora Advisors LLC | 82,048 | $207,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 4,600 | $1,372,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 25,499 | $64,000 | 0.00% |
| ATTICUS WEALTH MANAGEMENT, LLC | 2,425 | $6,000 | 0.00% |